Based on cell experiments, C6-ceramide has been shown to individually inhibit the growth of both KRAS wild-type and KRAS mutant CRC cell lines (SW48 and SW480, respectively), especially in SW480 cell line. The gene discussed is KRAS; the disease is colorectal carcinoma.